Oncology Biosimilars Market Size, Share & Industry Analysis, By Drug Class (Anti-HER2 Monoclonal Antibodies, Anti-VEGF Monoclonal Antibodies, Anti-CD20, and Immune Checkpoint Inhibitors), By Product (Trastuzumab, Bevacizumab, Rituximab, Pertuzumab, and Pembrolizumab), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Non-Hodgkin's Lymphoma, and Melanoma), By Age Group (Pediatric and Adults), By Route of Administration (Intravenous and Subcutaneous), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, and Retail Pharmacies), and Regional Forecast, 2026-2034